Cited by 3,605Angiogenesis and VEGF in CancerLymphatic System and DiseasesCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Kim, K. Jin, Li, Bing, Winer, Jane, Armanini, Mark, Gillett, Nancy, Phillips, Heidi S., Ferrara, Napoleone·1993·Nature

Open this paper in CoChat — free account

Abstract

The development of new blood vessels (angiogenesis) is required for many physiological processes including embryogenesis, wound healing and corpus luteum formation. Blood vessel neoformation is also important in the pathogenesis of many disorders, particularly rapid growth and metastasis of solid tumours. There are several potential mediators of tumour angiogenesis, including basic and acidic fibroblast growth factors, tumour necrosis factor-alpha and transforming factors-alpha and -beta. But it is unclear whether any of these agents actually mediates angiogenesis and tumour growth in vivo. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen and an angiogenesis inducer released by a variety of tumour cells and expressed in human tumours in situ. To test whether VEGF may be a tumour angiogenesis factor in vivo, we injected human rhabdomyosarcoma, glioblastoma multiforme or leiomyosarcoma cell lines into nude mice. We report here that treatment with a monoclonal antibody specific for VEGF inhibited the growth of the tumours, but had no effect on the growth rate of the tumour cells in vitro. The density of vessels was decreased in the antibody-treated tumours. These findings demonstrate that inhibition of the action of an angiogenic factor spontaneously produced by tumour cells may suppress tumour growth in vivo.

Integrity signals

Registry

Crossref · 10.1038/362841a0

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,598
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 5,000
Self-citation
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509
Angiogenesis.
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,651
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,269
Self-citation
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,262
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G. G., Sanzo, K., Warren, T. G., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,058
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,988
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
Ferrara, N., Houck, K. A., Jakeman, L. B., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Self-citation

Show all 32 references

Research works printed but not linked: 2

Senger, D., Perruzzi, C. A., Feder, J. & Dvorak, H. F. Cancer Res. 46, 5629 (1986).
Westphal, M. et al. Expl cell. Biol. 55, 152–161 (1987).

Sorted by citations

Items 401–500 of 1,006

On the Mechanism of Thrombin-induced Angiogenesis
Tsopanoglou, N. E., & Maragoudakis, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23969 · Cited by 220
Gastrointestinal Perforation Due to Bevacizumab in Colorectal Cancer
Saif, M. W., Elfiky, A. A., & Salem, R. R. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9337-9 · Cited by 220
Angiogenesis in brain tumors; pathobiological and clinical aspects
Wesseling, P., Ruiter, D. J., & Burger, P. C. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005746320099 · Cited by 222
Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo
Sgadari, C., Angiolillo, A. L., Cherney, B., Pike, S. E., Farber, J. M., Koniaris, L. G., Vanguri, P., Burd, P. R., Sheikh, N. M., Gupta, G. D., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13791 · Cited by 217
In vitro release of vascular endothelial growth factor during platelet aggregation
Maloney, J. P., Silliman, C. C., Ambruso, D. R., Wang, J., Tuder, R. M., & Voelkel, N. F. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.3.h1054 · Cited by 218
Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish
Lee, P. P., Goishi, K., Davidson, A. J., Mannix, R. J., Zon, L. I., & Klagsbrun, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162366299 · Cited by 216
Tumour Angiogenesis and Angiogenic Inhibitors: A Review
Yadav, L. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/12016.6135 · Cited by 216
Vascular Endothelial Growth Factor Modulates the Transendothelial Migration of MDA-MB-231 Breast Cancer Cells through Regulation of Brain Microvascular Endothelial Cell Permeability
Lee, T.-H., Avraham, H. K., Jiang, S., & Avraham, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210063200 · Cited by 214
Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo
Rosenstein, J. M., Mani, N., Silverman, W. F., & Krum, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7086 · Cited by 214
Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
Barleon, B., Siemeister, G., Martiny‐Baron, G., Weindel, K., Herzog, C., & Marmé, D. (1997) · PubMed · Cited by 214
MDM2 Promotes Cell Motility and Invasiveness by Regulating E-Cadherin Degradation
Yang, J.-Y., Zong, C. S., Xia, W., Wei, Y., Ali-Seyed, M., Li, Z., Broglio, K., Berry, D. A., & Hung, M.-C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00172-06 · Cited by 211
Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots
Chen, K., Li, Z., Wang, H., Cai, W., & Chen, X. S. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0860-8 · Cited by 213
Long non-coding RNA HOTAIR is associated with human cervical cancer progression
Kim, H. J., Lee, D. W., Yim, G. W., Nam, E. J., Kim, S., Kim, S. W., & Kim, Y. T. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2758 · Cited by 212
Alterations of expression of Rb, p16INK4A and cyclin D1 in non-small cell lung carcinoma and their clinical significance
Brambilla, E. M., Moro‐Sibilot, D., Gazzéri, S., & Brambilla, C. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199908)188:4 · Cited by 129
Trends and Challenges in Tumor Anti-Angiogenic Therapies
Jászai, J., & Schmidt, M. H. H. (2019) · Cells · doi:10.3390/cells8091102 · Cited by 215
MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor
Yu, Y., & Sato, J. D. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199902)178:2 · Cited by 210
Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer
Casey, T., Bond, J. P., Tighe, S. W., Hunter, T., Lintault, L., PATEL, O. V., Eneman, J. D., Crocker, A. M., White, J. H., Tessitore, J., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9982-8 · Cited by 214
The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome
Rizk, B. (1997) · Human Reproduction Update · doi:10.1093/humupd/3.3.255 · Cited by 211
Interleukin‐18 acts as an angiogenesis and tumor suppressor
Cao, R., Farnebo, J., Kurimoto, M., & Cao, Y. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2195 · Cited by 209
Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation
Clark, D. E., Smith, S. K., Licence, D., Evans, A. L., & Jones, D. S. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590459 · Cited by 219
Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice
Kim, L. S., Huang, S., Lu, W., Lev, D. C., & Price, J. E. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000024761.00373.55 · Cited by 210
Magnetic Resonance Imaging Detects Suppression of Tumor Vascular Permeability After Administration of Antibody to Vascular Endothelial Growth Factor
Pham, C. D., Roberts, T. P. L., van Bruggen, N., Melnyk, O. O., Mann, J. S., Ferrara, N., Cohen, R. L., & Brasch, R. C. (1998) · Cancer Investigation · doi:10.3109/07357909809039771 · Cited by 208
Self-citation
Meningiomas: Role of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Angiogenesis and Peritumoral Edema
Provias, J., Claffey, K. P., delAguila, L., Lau, N. C., Feldkamp, M. M., & Guha, A. (1997) · Neurosurgery · doi:10.1097/00006123-199705000-00027 · Cited by 206
The Expanding Role of Systemic Therapy in Head and Neck Cancer
Cohen, E. E. W., Lingen, M. W., & Vokes, E. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.147 · Cited by 207
Manipulating angiogenesis in medicine
Carmeliet, P. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2003.01297.x · Cited by 215
Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis.
Viti, F., Tarli, L., Giovannoni, L., Zardi, L., & Neri, D. (1999) · PubMed · Cited by 206
Cytokine networks in solid human tumors: regulation of angiogenesis
Leek, R., Harris, A. L., & Lewis, C. E. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.4.423 · Cited by 208
Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer
Tugues, S., Koch, S., Gualandi, L., Li, X., & Claesson, L. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.004 · Cited by 209
Therapeutic targeting of myeloid-derived suppressor cells
Ugel, S., Delpozzo, F., Desantis, G., Papalini, F., Simonato, F., Sonda, N., Zilio, S., & Bronte, V. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.014 · Cited by 207
Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells.
Yoshiji, H., Harris, S. R., & Thorgeirsson, U. P. (1997) · PubMed · Cited by 206
Suppression of Luteal Angiogenesis in the Primate after Neutralization of Vascular Endothelial Growth Factor1
Fraser, H. M., Dickson, S. E., Lunn, S. F., Wulff, C., Morris, K. D., Carroll, V. A., & Bicknell, R. (2000) · Endocrinology · doi:10.1210/endo.141.3.7369 · Cited by 205
A High-Affinity Human Antibody That Targets Tumoral Blood Vessels
Tarli, L., Balza, E., Viti, F., Borsi, L., Castellani, P., Berndorff, D., Dinkelborg, L. M., Neri, D., & Zardi, L. (1999) · Blood · doi:10.1182/blood.v94.1.192.413k22_192_198 · Cited by 204
Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy
Ferrara, N. (2010) · Nature Medicine · doi:10.1038/nm1010-1107 · Cited by 206
Self-citation
VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade
Rudge, J. S., Holash, J. A., Hylton, D., Russell, M., Jiang, S., Leidich, R., Papadopoulos, N. J., Pyles, E. A., Torri, A., Wiegand, S. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708865104 · Cited by 207
Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors.
Hatva, E., Kaipainen, A., Mentula, P. J., Jääskeläinen, J. E., Paetau, A. E., Haltia, M., & Alitalo, K. K. (1995) · Europe PMC (PubMed Central) · Cited by 203
Isotype-Dependent Inhibition of Tumor Growth In Vivo by Monoclonal Antibodies to Death Receptor 4
Chuntharapai, A., Dodge, K., Grimmer, K., Schroeder, K. A., Marsters, S. A., Koeppen, H., Ashkenazi, A., & Kim, K. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4891 · Cited by 203
Self-citation
Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody
Ryan, A. M., Eppler, D. B., Hagler, K. E., Bruner, R. H., Thomford, P. J., Hall, R. L., Shopp, G. M., & O’neill, C. A. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700115 · Cited by 202
Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
Shen, G. H., Ghazizadeh, M., Kawanami, O., Shimizu, H., Jin, E., Araki, T., & Sugisaki, Y. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1228 · Cited by 201
Pathogenesis of retinopathy of prematurity
Smith, L. E. H. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.03.030 · Cited by 205
Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma
Abdulrauf, S. I., Edvardsen, K., Ho, K. L., Yang, X. Y., Rock, J. P., & Rosenblum, M. L. (1998) · Journal of neurosurgery · doi:10.3171/jns.1998.88.3.0513 · Cited by 201
Roles for VEGF in the adult
Maharaj, A. S. R., & D'Amore, P. A. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.03.004 · Cited by 202
Biology of tumor cell invasion: Interplay of cell adhesion and matrix degradation
Heino, J. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960315)65:6 · Cited by 117
The second immunoglobulin‐like domain of the VEGF tyrosine kinase receptor Flt‐1 determines ligand binding and may initiate a signal transduction cascade.
Davis-Smyth, T., Chen, H., Park, J., Presta, L. G., & Ferrara, N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00872.x · Cited by 200
Self-citation
Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor.
Lin, P. C., Sankar, S., Shan, S. Q., Dewhirst, M. W., Polverini, P. J., Quinn, T. Q., & Peters, K. G. (1998) · PubMed · Cited by 199
Expression of vascular endothelial growth factor receptors in human prostate cancer
Ferrer, F. A., MILLER, L. J., Lindquist, R., Kowalczyk, P., Laudone, V. P., Albertsen, P. C., & Kreutzer, D. L. (1999) · Urology · doi:10.1016/s0090-4295(99)00156-9 · Cited by 198
Solution structure of the heparin-binding domain of vascular endothelial growth factor
Fairbrother, W. J., Champe, M., Christinger, H. W., Keyt, B. A., & Starovasnik, M. A. (1998) · Structure · doi:10.1016/s0969-2126(98)00065-3 · Cited by 197
Platelet Factor-4 Inhibits the Mitogenic Activity of VEGF121 and VEGF165 Using Several Concurrent Mechanisms
Gengrinovitch, S., Greenberg‐Sepersky, S. M., Cohen, T., Gitay-Goren, H., Rockwell, P., Maione, T. E., Levi, B.-Z., & Neufeld, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15059 · Cited by 203
Vascular endothelial growth factor and its receptors
Neufeld, G., Tessler, S., Gitay-Goren, H., Cohen, T., & Levi, B.-Z. (1994) · Progress in Growth Factor Research · doi:10.1016/0955-2235(94)90019-1 · Cited by 198
Vascular Endothelial Growth Factor Activates Nuclear Factor of Activated T Cells in Human Endothelial Cells: a Role for Tissue Factor Gene Expression
Armesilla, A. L., Lorenzo, E., Arco, P. G., Martı́nez-Martı́nez, S., Alfranca, A., & Redondo, J. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2032 · Cited by 198
Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
Pal, S., Datta, K., & Mukhopadhyay, D. (2001) · PubMed · Cited by 196
Specific Interaction of Angiostatin with Integrin αvβ3 in Endothelial Cells
Tarui, T., Miles, L. A., & Takada, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101815200 · Cited by 197
Inhibition of Vascular Endothelial Growth Factor (VEGF)-induced Endothelial Cell Proliferation by a Peptide Corresponding to the Exon 7-Encoded Domain of VEGF165
Söker, S., Gollamudi-Payne, S., Fidder, H. H., Charmahelli, H., & Klagsbrun, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31582 · Cited by 201
Angiogenesis: Models and Modulators
COCKERILL, G. W., Gamble, J. R., & Vadas, M. A. (1995) · International review of cytology · doi:10.1016/s0074-7696(08)62106-3 · Cited by 194
The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
Mendel, D. B., Schreck, R., West, D. C., Li, G., Strawn, L. M., Tanciongco, S. S., Vasile, S., Shawver, L. K., & Cherrington, J. M. (2000) · PubMed · Cited by 195
Immunomodulatory Activity of VEGF in Cancer
Lapeyre-Prost, A., Terme, M., Pernot, S., Pointet, A., Voron, T., Tartour, É., & Taı̈eb, J. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.09.007 · Cited by 203
Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
Liu, G., Chen, T., Ding, Z., Wang, Y., Wei, Y., & Wei, X. (2021) · Cell Proliferation · doi:10.1111/cpr.13009 · Cited by 196
Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.
Tessler, S., Rockwell, P., Hicklin, D., Cohen, T., Levi, B.-Z., Witte, L., Lemischka, I. R., & Neufeld, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99896-0 · Cited by 195
Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis
Claffey, K. P., & Robinson, G. S. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437469 · Cited by 194
Selective Binding of VEGF121 to One of the Three Vascular Endothelial Growth Factor Receptors of Vascular Endothelial Cells
Gitay-Goren, H., Cohen, T., Tessler, S., Söker, S., Gengrinovitch, S., Rockwell, P., Klagsbrun, M., Levi, B.-Z., & Neufeld, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5519 · Cited by 194
Flavonoids and Vitamin E Reduce the Release of the Angiogenic Peptide Vascular Endothelial Growth Factor from Human Tumor Cells
Schindler, R., & Mentlein, R. (2006) · Journal of Nutrition · doi:10.1093/jn/136.6.1477 · Cited by 193
Through The Eyes of a Child: Understanding Retinopathy through ROP The Friedenwald Lecture
Smith, L. E. H. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2584 · Cited by 195
Comparative expression pathway analysis of human and canine mammary tumors
Uva, P., Aurisicchio, L., Watters, J., Loboda, A. P., Kulkarni, A., Castle, J. C., Palombo, F., Viti, V., Mesiti, G., Zappulli, V., et al. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-135 · Cited by 198
Targeting the tumour vasculature: from vessel destruction to promotion
Guelfi, S., Hodivala‐Dilke, K., & Bergers, G. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00736-0 · Cited by 216
New paradigms for the treatment of cancer: The role of anti-angiogenesis agents
Cherrington, J. M., Strawn, L. M., & Shawver, L. K. (2000) · Advances in cancer research · doi:10.1016/s0065-230x(00)79001-4 · Cited by 194
Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization
Dougher, M. M., & Terman, B. I. (1999) · Oncogene · doi:10.1038/sj.onc.1202478 · Cited by 194
ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy.
Wedge, S. R., Ogilvie, D., Dukes, M., Kendrew, J., Curwen, J., Hennequin, L. F., Thomas, A., Stokes, E. S. E., Curry, B. J., Richmond, G., et al. (2000) · PubMed · Cited by 192
Renal cell carcinoma with retroperitoneal lymph nodes
Pantuck, A. J., Zisman, A., Dorey, F., Chao, D. H., Han, K., SAID, J. W., Gitlitz, B. J., Belldegrun, A. S., & Figlin, R. A. (2003) · Cancer · doi:10.1002/cncr.11422 · Cited by 192
Controlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapy
Fan, T. D., Jagger, R. T., & Bicknell, R. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88979-8 · Cited by 191
Transcatheter and Ablative Therapeutic Approaches for Solid Malignancies
Liapi, E. A., & Geschwind, J.-F. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.8657 · Cited by 191
Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase.
Wang, D., Huang, H., Kazlauskas, A., & Cavenee, W. K. (1999) · PubMed · Cited by 186
The Specificity of Receptor Binding by Vascular Endothelial Growth Factor-D Is Different in Mouse and Man
Baldwin, M. E., Catimel, B., Nice, E. C., Roufail, S., Hall, N. E., Stenvers, K. L., Karkkainen, M. J., Alitalo, K. K., Stacker, S. A., & Achen, M. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100097200 · Cited by 194
NADPH oxidase activity is required for endothelial cell proliferation and migration
Abid, M. R., Kachra, Z., Spokes, K., & Aird, W. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02305-x · Cited by 191
Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients
Kondo, S., Asano, M., Matsuo, K., Ohmori, I., & Suzuki, H. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90016-7 · Cited by 191
Molecular markers of prostate cancer outcome
Quinn, D. I., Henshall, S. M., & Sutherland, R. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.035 · Cited by 189
Transcriptional Activation of the Human Leptin Gene in Response to Hypoxia
Ambrosini, G., Nath, A. K., Sierra-Honigmann, M. R., & Flores-Riveros, J. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205172200 · Cited by 188
VEGF inhibition: insights from preclinical and clinical studies
Crawford, Y., & Ferrara, N. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0675-8 · Cited by 192
Self-citation
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth
Zhou, B., Ma, R., Si, W., Li, S., Yan, X., Tu, X., & Wang, Q. K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.028 · Cited by 188
Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy
Choi, Y., & Jung, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01114-w · Cited by 188
Antibody Neutralization of Vascular Endothelial Growth Factor Inhibits Wound Granulation Tissue Formation
Howdieshell, T. R., Callaway, D., Webb, W. L., Gaines, M. D., Procter, C. D., Sathyanarayana, Pollock, J. S., Brock, T. L., & McNeil, P. L. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2001.6089 · Cited by 188
Vascular Endothelial Growth Factor (VEGF) Expression in Prostate Cancer and Benign Prostatic Hyperplasia
Jackson, M., Bentel, J. M., & Tilley, W. D. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)64774-8 · Cited by 186
De novo expression of vascular endothelial growth factor in human pancreatic cancer: Evidence for an autocrine mitogenic loop
von Marschall, Z., Cramer, T., Höcker, M. R., Burde, R., Plath, T., Schirner, M., Heidenreich, R., Breier, G., Riecken, E., Wiedenmann, B., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.19578 · Cited by 190
Vascular endothelial growth factor
Ferrara, N. (1993) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(93)90046-9 · Cited by 188
Self-citation
Mechanisms of tumour metastasis
Meyer, T., & Hart, I. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10129-0 · Cited by 186
Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali, E., Zietz, C., Benelli, R., Weninger, W., Masiello, L., Breier, G., Tschachler, E., Albini, A., & Stürzl, M. (1996) · Europe PMC (PubMed Central) · Cited by 186
Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: an immunocytochemical study
Sonstein, W. J., Kader, A., Michelsen, W. J., Llena, J. F., Hirano, A., & Casper, D. (1996) · Journal of neurosurgery · doi:10.3171/jns.1996.85.5.0838 · Cited by 188
Distinct Role of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor on Tumor Growth and Angiogenesis
Giavazzi, R., Sennino, B., Coltrini, D., Garofalo, A., Dossi, R., Ronca, R., Molinari-Tosatti, M. P., & Presta, M. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64325-8 · Cited by 185
Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer.
Baker, C. H., Solórzano, C. C., & Fidler, I. J. (2002) · PubMed · Cited by 186
Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis.
Yoshiji, H., Kuriyama, S., Ways, D. K., Yoshii, J., Miyamoto, Y., Kawata, M., Ikenaka, Y., Tsujinoue, H., Nakatani, T., Shibuya, M., et al. (1999) · PubMed · Cited by 183
Molecular markers in oral epithelial dysplasia: review
Pitiyage, G. N., Tilakaratne, W. M., Tavassoli, M., & Warnakulasuriya, S. (2009) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2009.00804.x · Cited by 185
Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients With Recurrent Malignant Gliomas
Cuneo, K. C., Vredenburgh, J. J., Sampson, J. H., Reardon, D. A., Desjardins, A., Peters, K. B., Friedman, H. S., Willett, C. G., & Kirkpatrick, J. P. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.12.074 · Cited by 185
Suppression of angiogenesis and tumor growth by the inhibitor K1–5 generated by plasmin-mediated proteolysis
Cao, R., Wu, H., Veitonmäki, N., Linden, P. A., Farnebo, J., Shi, G.-Y., & Cao, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5728 · Cited by 185
Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
Sauter, E. R., Nesbit, M., Watson, J. C., Klein–Szanto, A. J., Litwin, S., & Herlyn, M. (1999) · PubMed · Cited by 185
Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin‐like growth factor binding protein‐3
Singh, R. P., Tyagi, A. K., Dhanalakshmi, S., Agarwal, R., & Agarwal, C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11620 · Cited by 185
Structure-Function Studies of Two Synthetic Anti-vascular Endothelial Growth Factor Fabs and Comparison with the Avastin™ Fab
Fuh, G., Wu, P., Liang, W., Ultsch, M. H., Lee, C. V., Moffat, B., & Wiesmann, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507783200 · Cited by 181
Tumor angiogenesis as a prognostic factor in oral cavity tumors
Williams, J. K., Carlson, G. W., Cohen, C., DeRose, P. B., HUNTER, S. B., & Jurkiewicz, M. J. (1994) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80079-0 · Cited by 184
Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor
Jellinek, D., Green, L. S., Bell, C., & Janjić, N. (1994) · Biochemistry · doi:10.1021/bi00200a028 · Cited by 185
Tailoring in Vitro Selection for a Picomolar Affinity Human Antibody Directed against Vascular Endothelial Growth Factor Receptor 2 for Enhanced Neutralizing Activity
Lü, D., Shen, J., Vil, M. D., Zhang, H., Jimenez, X., Böhlen, P., Witte, L., & Zhu, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307742200 · Cited by 183
Breast tumour angiogenesis
Fox, S. B., Generali, D., & Harris, A. L. (2007) · Breast Cancer Research · doi:10.1186/bcr1796 · Cited by 184
Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma
von Marschall, Z., Cramer, T., Höcker, M. R., Finkenzeller, G., Wiedenmann, B., & Rosewicz, S. (2001) · Gut · doi:10.1136/gut.48.1.87 · Cited by 182
Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I.
Akagi, Y., Liu, W., Zebrowski, B. K., Xie, K., & Ellis, L. M. (1998) · PubMed · Cited by 183

Authors: Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N.
Affiliations: Genentech (US)
ORCID: Li, Bing
Armanini, Mark
Phillips, Heidi S.
Ferrara, Napoleone
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1993-04
Volume: 362
Issue: 6423
Pages: 841-844
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/362841a0
OpenAlex: W1969328947
Cited by: 3,605
References: 32
Citations by year: 2026: 22 · 2025: 25 · 2024: 43 · 2023: 47 · 2022: 53 · 2021: 55 · 2020: 55 · 2019: 54 · 2018: 89 · 2017: 101 · 2016: 81 · 2015: 78 · 2014: 98 · 2013: 110 · 2012: 137
FWCI: 32.75
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: vascular endothelial growth factor, angiogenesis, tumor angiogenesis, tumor growth inhibition, monoclonal antibodies, rhabdomyosarcoma, glioblastoma, leiomyosarcoma, tumor vasculature, nude mice, tumour metastasis
MeSH terms: Animals, Antibodies, Monoclonal, Cell Division, Female, Glioblastoma, Humans, Leiomyosarcoma, Lymphokines, Mice, Nude, Neoplasm Transplantation, Neoplasms, Experimental, Neovascularization, Pathologic, Rhabdomyosarcoma, Tumor Cells, Cultured, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks